Delivery Order SPE2DB20D3103-SPE2DB23FP2A1
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRAXANE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $1,687.34 and a performance period extending through May 28, 2025. The contract is not set aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,375.16 contract is for the delivery of ABRAXANE 100 MG VIALS and has an ultimate completion date of March 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABRAXANE 100 MG VIALS, a medical product, with a firm fixed price ceiling value of $7,106.36 and a period of performance through June 12, 2025. The contract is not set-aside and was awarded on June 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
- This is a federal contract award to Amerisourcebergen Drug Corp for the delivery of ABRAXANE 100 mg vials, a specialty pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order with a firm fixed price of $42,197.40 and a period of performance through September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medication to support federal healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,841.20 firm fixed-price delivery order is for 4560863156 ABRAXANE 100 MG VIALS, with a performance period through May 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, with ID SPE2DB22D3016|SPE2DB24FBBU2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a ceiling value of $7,283.84 and an ultimate completion date of July 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for ABRAXANE 100 MG VIALS. The $14,980.02 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which runs through November 2026. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP2A1Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ABRAXANE 100 MG vials, a specialty pharmaceutical product. The contract has a ceiling value of $10,145.58 and a completion date of August 2, 2023. The contract is not designated with a set-aside requirement, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs enable the company to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 8/1/23 |